Just over half of U.S. adults (53%) say they’ve gotten neither the flu shot nor the updated COVID-19 vaccine since last ...

[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the United States set an audacious goal in January last year to develop a coronavirus vaccine within 12 to ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Next: Get access to a new market-moving chart every ... company’s COVID-19 vaccines due to reduced market demand. In addition, write-downs by BioNTech’s collaboration partner Pfizer Inc ...

The latest generation of COVID-19 vaccines demonstrates remarkable precision in addressing current viral threats. The mRNA vaccines from Pfizer and Moderna specifically target the KP.2 variant ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...

Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

The researchers identified 1248 major structural birth defects among 78,052 pregnancies: 1049 in unvaccinated people and 199 in vaccinated people (160.6 and 156.4 per 10,000 live births, respectively) ...

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, ...